Walleye Capital LLC Perkinelmer Inc Call Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	N/A	-11,700 Reduced 72.22%	4,500 $544,000
Q2 2024 Aug 14, 2024	BUY	N/A	9,100 Added 128.17%	16,200 $1.96 Million
Q1 2024 May 15, 2024	SELL	N/A	-33,300 Reduced 82.43%	7,100 $859,000
Q4 2023 Feb 14, 2024	BUY	N/A	34,800 Added 621.43%	40,400 $4.89 Million
Q3 2023 Nov 14, 2023	BUY	$115.88 - $122.81 $648,928 - $687,736	5,600 New	5,600 $677,000
Q1 2023 May 15, 2023	BUY	$120.16 - $144.38 $973,296 - $1.17 Million	8,100 New	8,100 $1.08 Million
Q1 2020 May 15, 2020	SELL	$66.71 - $101.73 $1.91 Million - $2.92 Million	-28,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$79.1 - $97.45 $798,910 - $984,245	10,100 Added 54.3%	28,700 $2.79 Million
Q3 2019 Nov 14, 2019	SELL	$79.44 - $98.79 $79,440 - $98,790	-1,000 Reduced 5.1%	18,600 $1.58 Million
Q2 2019 Aug 14, 2019	SELL	$84.06 - $101.12 $537,984 - $647,168	-6,400 Reduced 24.62%	19,600 $1.89 Million
Q1 2019 May 15, 2019	BUY	$72.79 - $97.5 $1.89 Million - $2.54 Million	26,000 New	26,000 $2.51 Million

575

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.